Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.5 (
RNase
)
17,967
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have cloned a new human matrix metalloproteinase (MMP-28,
epilysin
) from human keratinocyte and testis cDNA libraries. Like most MMPs,
epilysin
contains a signal sequence, a prodomain with a PRCGVTD sequence, a zinc-binding catalytic domain with an HEIGHTLGLTH sequence, and a hemopexin-like domain. In addition,
epilysin
has a furin activation sequence (RRKKR) but has no transmembrane sequence. The exon-intron organization and splicing pattern of
epilysin
differ from that of other MMP genes. It has only 8 exons, and 5 exons are spliced at sites not used by other MMPs. Another novel feature of
epilysin
is that exon 4 is alternatively spliced to a transcript that does not encode the N-terminal half of the catalytic domain. Northern hybridization of tissue RNA indicated that
epilysin
is expressed at high levels in testis and at lower levels in lungs, heart, colon, intestine, and brain.
RNase
protection assay with various cell lines indicated that
epilysin
was selectively expressed in keratinocytes. Recombinant
epilysin
degraded casein in a zymography assay, and its proteolytic activity was inhibited by EDTA and by batimastat, a selective MMP inhibitor. Immunohistochemical staining showed expression of
epilysin
protein in the basal and suprabasal epidermis of intact skin. In injured skin, prominent staining for
epilysin
was seen in basal keratinocytes both at and some distance from the wound edge, a pattern that is quite distinct from that of other MMPs expressed during tissue repair. These findings suggest that this new MMP functions in several tissues both in tissue homeostasis and in repair.
...
PMID:Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. 1112 98
Epilysin (MMP-28) is a recently cloned member of the matrix metalloproteinase family (Lohi et al., J. Biol. Chem. 276 (2001) 10134). It is expressed at highest levels in the skin by basal and suprabasal keratinocytes, and in testis by developing germ cells. To characterize the
epilysin
promoter, we isolated a 3.0 kb fragment of human genomic DNA containing 5'-flanking sequence of the
epilysin
gene, and a corresponding 660 bp fragment from the mouse. The 5'-flanking sequences contain no typical TATA-boxes or CCAAT sequences close to the translation initiation sites.
RNase
protection assay revealed that two transcription start sites are utilized in the human
epilysin
gene, situated 210 and 230 bp upstream from the translation start site. The promoter contains a GT-box, situated 300 bp upstream from the translation start site, with homology to the consensus binding site for transcription factors of the Sp family. This site is perfectly conserved between the human and mouse promoters. For reporter gene assays a series of constructs with fragments of increasing length of the
epilysin
promoter were coupled to the firefly luciferase gene. Reporter gene assays indicated that deletion or mutation of the GT-box dramatically reduces the transcriptional activity both in keratinocytes and in spermatogonia. Gel mobility shift assays showed that several nuclear proteins bind specifically to this sequence. Supershift assays with antibodies specific for members of the Sp family identified Sp1 and Sp3 as components of these protein/DNA complexes and hence as possible regulators of the
epilysin
gene. Our results indicate that the
epilysin
promoter has distinctive structural and functional features, which may control the unique expression and regulation patterns of the
epilysin
gene.
...
PMID:Promoter characterization of the human and mouse epilysin (MMP-28) genes. 1157 68